Arclin will significantly expand its North American production of methylamines and dimethylformamide (DMF) at its West Virginia facility.
The investment reflects rising domestic demand and the company’s commitment to diversifying its product offerings across key industries.
New capacities are expected to be operational by the end of 2026.